The second of two articles summarizing the broad range of government efforts to control drug pricing focuses on state government efforts.
Jamie Van Iderstine
Advertisement
Jamie Van Iderstine, Cyan Health
Articles by Jamie Van Iderstine
Advertisement
Latest Updated Articles
- A Pricing Revolution: The State Offensive
Published: October 30th 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Johnson and Johnson’s Darzalex Faspro for Adults with High-Risk Smoldering Multiple Myeloma
2
Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1s to TrumpRX
3
In Obesity Care, NPs and PAs Are the Influencers Marketers Can’t Ignore
4
FDA Continues to Expand National Priority Voucher Program
5
